ArticleJournal of immunology (Baltimore, Md. : 1950)2013

Programmed death receptor-1/programmed death receptor ligand-1 blockade after transient lymphodepletion to treat myeloma.

Tyce J Kearl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.